The Conway Police Department's Community Crisis Response Team enhanced its mental health crisis response and data management efficiency by adopting NewOrg's centralized, customizable data system.
Read More
Black Book Research Introduces 18 AI-Focused KPIs to Deeply Evaluate Machine Learning, Data Integration, and Real-World Impact in Population Health and Value-Based Care
Read MoreProven Industry Leader Brings Deep Relationships and Extensive Expertise Across all Facets of Leisure, Travel and Tourism
Five Star Alliance Now Directing Group Booking Inquiries to NextTrip
NextTrip to Launch New Cruise Booking Engine in the First Half of 2025
Read More
Innovative hair care brand merges science with style to formulate products that repair and strengthen all hair types, and empower women with confidence, self-expression, and noticeably healthy hair.
Read More
New Industry KPIs for Evaluating PHM & VBC IT Vendors Prioritize AI-Driven Insights, Workflow Automation, and Real-World Clinical Impact - Top 2025 Vendors Recognized for Effectiveness and Client Experience
Read MoreStrategic partnership's multi-modal approach significantly enhances homeland security agencies' ability to detect and mitigate threats before they escalate, revolutionizing border security with persistent remote aerial operations and emergency response
Volatus' extensive sales, marketing, field support, and services capabilities extend Ondas' market reach and accelerate market penetration for the Optimus System
The Optimus System to be deployed as drone infrastructure for completely remote, autonomous operations providing aerial security and intelligence for sensitive locations, critical operations and assets
Read More
- This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -
- The Company recently entered into a Clinical Trial Collaboration Agreement with Revance to study DMT410 for the treatment of axillary hyperhidrosis -
- The Company also has an issued patent in Japan covering their DMT410 program for the treatment of hyperhidrosis -
Read MoreInitial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete
Test results support the next development step with Phase 1clinical trial expected to commence in April
Provides Summary of Expected 2025 Milestones
Read More